Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance (LRA), today announced a pioneering funding ...

By targeting these receptors directly, Tanaka and colleagues hoped to shut down lupus pathology at the earliest point in the process, preventing interferon release and the subsequent autoimmune ...

We investigate how candidate pathogenic bacteria in gut communities affect the immune system and potentially affect autoimmune disease activity.

Lupus Therapeutics introduces the IDEAL Initiative to fund clinical studies exploring the impact of diet and the microbiome ...

Linkage studies type microsatellite markers across the whole genome in pedigrees with at least two systemic lupus erythematosus (SLE) patients and define a large linkage region. Association ...

Studies investigating what is damaging the kidney in lupus nephritis point to tubulointerstitial inflammation.